MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $538,000 | -6.1% | 7,700 | -9.7% | 0.01% | -28.6% |
| Q2 2022 | $573,000 | +28.5% | 8,525 | +236.8% | 0.01% | -50.0% |
| Q3 2021 | $446,000 | -41.5% | 2,531 | -46.3% | 0.03% | +55.6% |
| Q2 2021 | $762,000 | -17.0% | 4,716 | -12.0% | 0.02% | -48.6% |
| Q1 2021 | $918,000 | -3.0% | 5,357 | +24.4% | 0.04% | -5.4% |
| Q4 2020 | $946,000 | +244.0% | 4,306 | +159.9% | 0.04% | +105.6% |
| Q3 2020 | $275,000 | -65.9% | 1,657 | -76.5% | 0.02% | -63.3% |
| Q2 2020 | $806,000 | – | 7,059 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |